持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/08/15 | 8,180 | 8,210 | 8,120 | 8,170 | +30 | +0.4% | 21,200 |
2017/08/14 | 8,190 | 8,220 | 8,100 | 8,140 | -160 | -1.9% | 34,400 |
2017/08/10 | 8,100 | 8,300 | 8,100 | 8,300 | +230 | +2.9% | 53,400 |
2017/08/09 | 8,160 | 8,180 | 8,010 | 8,070 | -90 | -1.1% | 40,500 |
2017/08/08 | 8,180 | 8,240 | 8,140 | 8,160 | -50 | -0.6% | 31,300 |
2017/08/07 | 8,080 | 8,210 | 8,080 | 8,210 | +140 | +1.7% | 44,600 |
2017/08/04 | 8,060 | 8,080 | 8,040 | 8,070 | +20 | +0.2% | 25,400 |
2017/08/03 | 8,040 | 8,070 | 8,000 | 8,050 | +10 | +0.1% | 21,300 |
2017/08/02 | 8,060 | 8,080 | 8,000 | 8,040 | +10 | +0.1% | 44,000 |
2017/08/01 | 7,750 | 8,050 | 7,710 | 8,030 | +340 | +4.4% | 72,500 |
2017/07/31 | 7,600 | 7,850 | 7,600 | 7,690 | +40 | +0.5% | 88,300 |
2017/07/28 | 7,600 | 7,650 | 7,590 | 7,650 | +10 | +0.1% | 20,000 |
2017/07/27 | 7,620 | 7,680 | 7,610 | 7,640 | +20 | +0.3% | 24,100 |
2017/07/26 | 7,680 | 7,680 | 7,590 | 7,620 | -10 | -0.1% | 30,200 |
2017/07/25 | 7,610 | 7,650 | 7,610 | 7,630 | -20 | -0.3% | 18,600 |
2017/07/24 | 7,700 | 7,720 | 7,610 | 7,650 | -80 | -1% | 29,000 |
2017/07/21 | 7,760 | 7,780 | 7,720 | 7,730 | -90 | -1.2% | 25,500 |
2017/07/20 | 7,750 | 7,850 | 7,740 | 7,820 | +70 | +0.9% | 20,100 |
2017/07/19 | 7,760 | 7,790 | 7,710 | 7,750 | ±0 | ±0% | 39,200 |
2017/07/18 | 7,820 | 7,820 | 7,720 | 7,750 | -90 | -1.1% | 28,600 |
2017/07/14 | 7,860 | 7,870 | 7,810 | 7,840 | +30 | +0.4% | 30,600 |
2017/07/13 | 7,940 | 7,940 | 7,800 | 7,810 | -40 | -0.5% | 23,800 |
2017/07/12 | 7,940 | 7,940 | 7,840 | 7,850 | -40 | -0.5% | 25,600 |
2017/07/11 | 7,810 | 7,910 | 7,800 | 7,890 | +50 | +0.6% | 24,000 |
2017/07/10 | 7,940 | 7,940 | 7,840 | 7,840 | -40 | -0.5% | 29,600 |
2017/07/07 | 7,920 | 7,940 | 7,860 | 7,880 | -80 | -1% | 34,400 |
2017/07/06 | 8,010 | 8,030 | 7,940 | 7,960 | -10 | -0.1% | 25,300 |
2017/07/05 | 8,010 | 8,040 | 7,920 | 7,970 | -40 | -0.5% | 26,700 |
2017/07/04 | 8,080 | 8,090 | 7,980 | 8,010 | -80 | -1% | 33,400 |
2017/07/03 | 8,020 | 8,130 | 8,020 | 8,090 | -10 | -0.1% | 36,600 |
2017/06/30 | 8,050 | 8,120 | 8,040 | 8,100 | -100 | -1.2% | 38,000 |
2017/06/29 | 8,050 | 8,210 | 8,040 | 8,200 | +150 | +1.9% | 56,900 |
2017/06/28 | 8,100 | 8,120 | 8,050 | 8,050 | -50 | -0.6% | 31,500 |
2017/06/27 | 8,140 | 8,170 | 8,090 | 8,100 | -40 | -0.5% | 29,300 |
2017/06/26 | 8,140 | 8,190 | 8,110 | 8,140 | +40 | +0.5% | 39,300 |
2017/06/23 | 8,080 | 8,130 | 8,060 | 8,100 | +10 | +0.1% | 29,500 |
2017/06/22 | 8,060 | 8,110 | 8,060 | 8,090 | +30 | +0.4% | 23,500 |
2017/06/21 | 7,990 | 8,090 | 7,990 | 8,060 | +40 | +0.5% | 31,500 |
2017/06/20 | 7,950 | 8,060 | 7,900 | 8,020 | +60 | +0.8% | 40,200 |
2017/06/19 | 7,840 | 7,990 | 7,830 | 7,960 | +60 | +0.8% | 40,200 |
2017/06/16 | 7,970 | 8,000 | 7,880 | 7,900 | -30 | -0.4% | 55,600 |
2017/06/15 | 7,860 | 7,990 | 7,830 | 7,930 | +120 | +1.5% | 50,500 |
2017/06/14 | 7,840 | 7,900 | 7,810 | 7,810 | +20 | +0.3% | 41,400 |
2017/06/13 | 7,860 | 7,870 | 7,790 | 7,790 | -60 | -0.8% | 30,600 |
2017/06/12 | 7,720 | 7,910 | 7,720 | 7,850 | +130 | +1.7% | 64,500 |
2017/06/09 | 7,770 | 7,830 | 7,700 | 7,720 | -50 | -0.6% | 55,600 |
2017/06/08 | 7,780 | 7,830 | 7,740 | 7,770 | -20 | -0.3% | 40,900 |
2017/06/07 | 7,910 | 7,910 | 7,780 | 7,790 | -90 | -1.1% | 50,600 |
2017/06/06 | 8,030 | 8,030 | 7,880 | 7,880 | -180 | -2.2% | 44,500 |
2017/06/05 | 8,000 | 8,080 | 7,980 | 8,060 | +60 | +0.8% | 50,300 |
1901~
1950
件表示中 / 3709件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 298,700円 | +5.1% | -7.0% | 2.68% | 19.61倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
東和薬品 | 306,000円 | +7.9% | -3.3% | 2.61% | 8.51倍 | 0.88倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 217,700円 | +3.1% | -6.5% | 2.20% | 10.10倍 | 1.07倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 149,300円 | -2.4% | -52.3% | 3.82% | 17.87倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 91,800円 | +20.3% | - | 0.00% | 162.76倍 | 1.21倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム